A company needs the best people, advanced science, great products, the physical plant, the right operations, the financial wherewithall, the right leadership, appropriate patients, experienced investigators, a good dose of common sense, a vision of the future, and some luck to develop significant new products. Many companies may possess these attributes; however, how well companies can pull all these manifold, often disparate, and sometimes conflicting resources together in turn will differentiate themselves as leading companies. A metaphor for this situation is the pack elephant (“the product”) and the five different blind passengers (“the departments”) needing to reach a common destination (“approvals”). Each may touch the elephant at different areas, large flappy ears, stumpy legs, long flexible trunk, hard pointy tusks, the tail, or the broad back. Besides their different personal experiences and expectations, they each believe to be holding a different animal with different possible benefits and risks in reaching their destination. Someone or some group must be able to step back and see the whole animal, as well as its parts, to coordinate the individual players, help make the best judgments, and set the best direction. Governance and planning can be best practices in pulling it all together in product development and in differentiating the top companies from the pack. These best practices are needed for the products (the elephants), by the departments (the elephants’ passengers), and by the whole company (the elephants’ whole environment), as well as for all stages at which a product exists or at any stage of a company in its evolution. It is very easy to be myopic and become lost in the details and not focus on the big picture. In this chapter and book, we are focusing on the many common challenges associated with product development, always keeping in mind the big picture (the big outcome)—product approvals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Guy P. Rising to the productivity challenge. A strategic framework for biopharma. Boston Consulting Group. July 2004.
Engel S, King J. Biotech innovation. Pipeline gaps. Can biotech fill them? R&D Directions 2004;10(7):42–56.
Booth B, Zemmell R. Prospects for productivity. Nature Reviews Drug Discovery 2004;3(5):451–6.
Rawlins MD. Cutting the cost of drug development. Nature Reviews Drug Discovery 2004;3(4):360–4.
Cohen CM. A path for improved pharmaceutical productivity. Nature Reviews Drug Discovery 2003;2(9):751–3.
R&D business. Mostly growth for big pharma in 2003. R&D Directions 2004;10(3):14–15.
Booth B, Zemmel R. Quest for the best. Nature Reviews Drug Discovery 2003;2(10):838–41.
Lawyer P, Kirstein A, Yabuki H, Gjaja M, Kush D. High science: a best-practice formula for driving innovation. In Vivo The Business & Medicine Report 2004;22(4):1–12.
Malek J. The path to smart R&D. Pharmaceutical Executive 2003;23(11):70–80.
Engel S. How to manage a winning pipeline. R&D Directions 2002;8(2):36–41.
The pipeline problem. The pipeline solution. R&D Directions 2004;10(5):42–54.
Tollman P, Goodall S, Ringel M. Good governance gives good advice. BCG Focus. Boston Consulting Group. 2004.
Tollman P, Guy P, Altshuler J, Flanagan A, Steiner M. A revolution in R&D. How genomics and genetics are transforming the biopharmaceutical industry. Boston Consulting Group, November 2001.
Preziosi P. Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario? Nature Reviews Drug Discovery 2004;3(6):521–6.
Balekdjian D, Russo M. Managed care update: show us the value. Pharmaceutical Executive special report. September 2003.
Kaitin KI (ed.). Decline in drug approvals is driving industry, FDA to enhance efficiency. Impact Report, Tufts Center for the Study of Drug Development 2005:7(1):1–6.
Tufts CSDD. Outlook 2005;1–8.
Tufts CSDD. Outlook 2004;1–8.
Tufts CSDD. Outlook 2003;1–5.
Tufts CSDD. Outlook 2002;1–5.
Tufts CSDD. Outlook 2001;1–5.
R&D Directions 2004 Drug Development Summit, How to Build and Maintain a Winning Pipeline. Feb. 8–11, 2004.
Anonymous. Report to the nation 2003. Improving public health through human drugs. Center for Drug Evaluation and Research. Food and Drug Administration. U.S. Department of Health and Human Services.
Kotter J. What Leaders Do. Harvard Business Review Book. Cambridge, MA. 1999.
Walton M. The Deming Management Method. Putnam Books, New York. 1986.
Covey SR. Seven Habits of Highly Successful People. Simon & Schuster, New York. 1989.
Heider J. Leadership of Tao. Humanics New Age, Atlanta, GA. 1985.
Pitino R. Success is a Choice. Ten Steps to Overachieving in Business and Life. Broadway Books, Bantam Doubleday Dell Publishing Group, New York. 1997.
Maxwell JC. The 21 Irrefutable Laws of Leadership. Maxwell Motivation Inc, Thomas Nelson, Nashville, TN. 1998.
Bynum WC, Cox J. Zapp! The Lightening of Empowerment. Harmony Books, New York. 1988.
Peters T, Waterman Jr RH. In Search of Excellence. Lessons from America's Best-run Companies. Warner Books. Harper & Row Publishers, New York. 1982.
Dupree M. Leadership Jazz. Dell Publishing, New York. 1992.
Kouzes JM, Posner BZ. The Leadership Challenge. How to Keep Getting Extraordinary Things Done in Organizations. Josey-Bass Publishers. San Francisco, CA. 1997.
Frankel LP. Overcoming Your Strengths. Harmony Books, New York. 1997.
Welch J. Leadership and Mangement. The 2002 Linkage Excellence in Management & Leadership Series. Linkage, Inc. Lexington, MA. 2002.
Bennis W. The Essence of Leadership. The Linkage Leadership and Strategy Series and PBS The Business Channel. Lexington, MA. 1999.
Shelton K (ed.). A New Paradigm of Leadership. Visions of Excellence for 21st Century Organizations. Executive Leadership Publishing, Provo, UT. 1997.
Albright M. Global Leadership. 2001 Linkage Excellence in Management & Leadership Series. Linkage Inc. 2001.
Vander Walde L, Choi K, Higgins J. Health Care Industry Market Update. Pharmaceuticals. Centers for Medicare and Medicaid Services. U.S. Department of Health and Human Services. January 2003, 1–52.
Anonymous. Profile pharmaceutical Industry 2004, Focus on innovation. PhRMA. 2004.
Kennedy T (ed). Pharmaceutical Project Management. Drugs and the Pharmaceutical Sciences, Vol. 86. Marcel Dekker, New York. 1998.
Cooper RG, Edgett SJ, Kleinschmidt EJ. Portfolio Management for New Products. Perseus Publishing, Cambridge, MA. 2001.
Boesig C. Why NDAs fail. 15 pitfalls and how to avoid them. R&D Directions 2003;9(2):26–42.
Razavi H. Managing and valuing the development pipeline in a major pharmaceutical company. DIA Annual Meeting, June 17, 2003, Chicago, IL.
Lamberti MJ (ed). An Industry in Evolution, 4th ed. Thomson, CenterWatch. 2003.
King J. Today's drug discovery unlocking greater potential. R&D Directions 2004;10(2):28–39.
Engel S. Drug-discovery companies aim for commercialization. Good leads good medicine. R&D Directions 2002;8(7):34–42.
Lam MD. Knowing when to pull the plug on your experimental drug. Pharmaceutical Executive 2004;24(2):55–60.
Bernard S. The 5 myths of pharmacogenomics. Pharmaceutical Executive 2003;23(10):70–8.
Shah J. Economic and regulatory considerations in pharmacogenomics for drug licensing and healthcare. Nature Biotechnology 2003;21(7):747–753.
King J. Can a drug live forever? R&D Directions 2003; 9(4):40–52.
Ho JH. Extending the product lifeline. Pharmaceutical Executive 2003;23(7):70–76.
Li G, Dalton D. Balanced scorecard for R&D. Pharmaceutical Executive 2003;23(10):84–90.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Evens, R.P., Covinsky, J. (2007). R&D Planning and Governance. In: Evens, R.P. (eds) Drug and Biological Development. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-69094-0_2
Download citation
DOI: https://doi.org/10.1007/978-0-387-69094-0_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-32978-9
Online ISBN: 978-0-387-69094-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)